Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21625543 | 0.82 | CA1 (0.42) | POLBNPSR1L3MBTL1GAATSHR | |
| SCHEMBL4284749 | 0.74 | GAA (0.41) | POLBNPSR1L3MBTL1KDM4EGAA | |
| Potassium Ion SCHEMBL27651589 | 0.72 | ALDH1A1 (0.43) | POLBKDM4EGAACA1CA2 | |
| SCHEMBL27501119 | 0.72 | CA1 (0.33) | GAACA1CA2 | |
| SCHEMBL1396234 | 0.71 | ALDH1A1 (0.45) | POLBKDM4EGAACA1CA2 | |
| SCHEMBL11027147 | 0.71 | SMN1; SMN2 (0.33) | — | |
| SCHEMBL27951710 | 0.70 | ALDH1A1 (0.44) | POLBKDM4EGAACA1CA2 | |
| SCHEMBL29117322 | 0.70 | SMN1; SMN2 (0.33) | — | |
| SCHEMBL5006830 | 0.69 | KDM4E (0.42) | KDM4ECA1CA2ALDH1A1 | |
| SCHEMBL29117326 | 0.69 | CHRM2 (0.34) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3919511-A1 | REAGENT KIT, MEASUREMENT KIT, AND MEASUREMENT METHOD | FUJIFILM Corporation (JP) | 2021-12-08 | — | — | EP | disclosed |
| EP-3919510-A1 | REAGENT KIT, MEASUREMENT KIT AND MEASUREMENT METHOD | FUJIFILM Corporation (JP) | 2021-12-08 | — | — | EP | disclosed |
| EP-2677317-B1 | Method for treating a blood component containing sample | ARKRAY INC (JP) | 2021-04-28 | — | — | EP | disclosed |
| EP-3425652-A1 | CONDUCTIVE POLYMER COMPOSITION, CONDUCTIVE-POLYMER-CONTAINING POROUS BODY AND MANUFACTURING METHOD THEREFOR, AND SOLID ELECTROLYTIC CAPACITOR AND MANUFACTURING METHOD THEREFOR | Idemitsu Kosan Co., Ltd. (JP) | 2019-01-09 | — | — | EP | disclosed |
| CN-105572389-A | Method for measuring glycosylated hemoglobin, measurement reagent, and measurement kit | KYOWA MEDEX CO LTD | 2016-05-11 | — | — | CN | disclosed |
| CN-105452863-A | Hemolytic streptococcus diagnostic immunochromatography reagent, kit and detection method | TANAKA PRECIOUS METAL IND | 2016-03-30 | — | — | CN | disclosed |
| CN-103069003-B | Method for measuring glycated hemoglobin | KYOWA MEDEX CO.,LTD. (JP) | 2016-01-20 | — | — | CN | disclosed |
| CN-104093852-B | Suppress the method for the impact of xitix | KYOWA MEDEX CO.,LTD. (JP) | 2015-11-25 | — | — | CN | disclosed |
| CN-103080239-B | Method for preserving aqueous solution containing leuco chromogen | KYOWA MEDEX CO LTD | 2015-03-25 | — | — | CN | disclosed |
| CN-104321428-A | Method for stabilizing ascorbic acid oxidase | KYOWA MEDEX CO LTD | 2015-01-28 | — | — | CN | disclosed |
| US-20060142209-A1 | Glucopyranosyloxypyrazole derivatives and medicinal use thereof | KISSEI PHARMACEUTICAL CO., LTD. | 2006-06-29 | — | — | US | disclosed |
| CN-1777608-A | fused pyrimidine derivatives | KYOWA HAKKO KOGYO KK (JP) | 2006-05-24 | — | — | CN | disclosed |
| CN-1238363-C | Glucopyranosyloxypyrazole derivatives and use thereof in medicines | KISSEI PHARMACEUTICAL (JP) | 2006-01-25 | — | — | CN | disclosed |
| CN-1694965-A | Method and reagent for measuring cholesterol in high-density lipoprotein | KYOWA MEDEX CO LTD (JP) | 2005-11-09 | — | — | CN | disclosed |
| CN-1537114-A | Nitrogenous heterocyclic derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor | ����ҩƷ��ҵ��ʽ���� | 2004-10-13 | — | — | CN | disclosed |
| CN-1492873-A | Glucopyranosyloxypyrazole derivatives and their use in medicaments | ����ҩƷ��ҵ��ʽ���� | 2004-04-28 | — | — | CN | disclosed |
| CN-1145635-C | Glucopyranosyloxypyrazole derivatives, pharmaceutical compositions containing the same and intermediates in their preparation | ����ҩƷ��ҵ��ʽ���� | 2004-04-14 | — | — | CN | disclosed |
| EP-1354888-A1 | GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND USE THEREOF IN MEDICINES | Kissei Pharmaceutical Co., Ltd. (JP) | 2003-10-22 | — | — | EP | disclosed |
| CN-1377363-A | Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof | KISSEI PHARMACEUTICAL (JP) | 2002-10-30 | — | — | CN | disclosed |
| EP-0190791-A1 | Calibration liquid for ion-specific electrodes, process for preparing them and their application | Stichting Gastransport (NL) | 1986-08-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060142209-A1 | Glucopyranosyloxypyrazole derivatives and medicinal use thereof | SLC5A2, SLC5A1, UGGT1 | POLB 4553/4885NPSR1 2607/4885L3MBTL1 2163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.